Opinion

Video

Overview of the Port Delivery System with Ranibizumab

Margaret Chang, MD, examines the difficulties of frequent anti-VEGF injections and outlines the key aspects of the port delivery system (PDS) for ranibizumab administration.

  1. Why is sustained delivery of anti-VEGF necessary, and what challenges arise from frequent anti-VEGF injections?
  2. Can you provide an overview of the port delivery system with ranibizumab?
    1. How does the device function?
    2. How is the device implanted?
    3. How is the device refilled?
  3. What are the benefits of using the PDS with ranibizumab, and which patients are ideal candidates for this delivery method?
Related Videos
Image credit: Ophthalmology Times; Angiogenesis 2025: Encapsulated cell therapy for MacTel shows long-term efficacy in phase 3 trials
Image credit: Ophthalmology Times; Dean McGee Eye Institute resident Ashley Ooms, MD, explores gray area strabismus surgery complications in AUPO poster
Image credit: Ophthalmology Times; EnVision Summit 2025: Sonia H. Yoo, MD, shares what to expect from the cataract and refractive agenda
Ophthalmology Times: Kathryn Colby, MD, PhD, reflects on National Women Physicians Day
© 2025 MJH Life Sciences

All rights reserved.